Asprosin, a novel glucogenic adipokine, is encoded by two exons (exon 65 and exon 66) of
the gene Fibrillin 1 (FBN1) and mainly synthesized and released by white adipose tissue …

Adipose tissue malfunction leads to altered adipokine secretion which might consequently
contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus …

Abstract Aims/Introduction Asprosin is a novel secreted adipokine that is induced by fasting
and promotes hepatic glucose release. In healthy humans, circulating asprosin shows …

Objective: Asprosin, a novel peptide that has recently discovered as an important regulatory
adipokine, is relevant to obesity in animals and adult humans. Little is known about its roles …

White adipose tissue is a dynamic endocrine organ that releases an array of adipokines,
which play a key role in regulating metabolic homeostasis and multiple other physiological …

Metabolic syndrome is a cluster of metabolic indicators that increase the risk of diabetes and
cardiovascular diseases. Visceral obesity and factors derived from altered adipose tissue …

Background: Circulating asprosin is a newly discovered adipokine that triggers the release
of hepatic glucose stores and increases appetite. Asprosin levels are elevated in adult …

The aim of this study was to examine the acute effect of aerobic exercise when performed in
the morning and evening on obesity-related hormones of asprosin, spexin, lipocalin-2, and …

Asprosin is a recently discovered protein released during fasting conditions mainly by
adipocytes from white adipose tissue. As a glucogenic peptide, it stimulates the release of …

Adipose tissue is a dynamic endocrine organ, secreting a plethora of adipokines which play
a key role in regulating metabolic homeostasis and other physiological processes. An …